Zdrowie i gospodarka · 29/12/2014
Next Generation Sequencing Diagnostic Tests; Public Workshop; Request for Comments
The Food and Drug Administration (FDA) is announcing the following public workshop entitled "Optimizing FDA's Regulatory Oversight of Next Generation Sequencing Diagnostic Tests." The purpose of this workshop is to discuss and receive feedback from the community on the questions in the discussion paper on diagnostic tests for human genetics or genomics using next generation sequencing (NGS) technology.